Cannabis and ALS: Exploring the Potential Therapeutic Benefits

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a neurodegenerative disorder that affects the nerve cells of voluntary muscle movement. There is no cure for ALS, but existing treatments aim to relieve symptoms and improve quality of life. Cannabis has been studied as a possible adjunctive treatment for ALS, with preliminary results suggesting benefits for patients. However, more research is needed to confirm these effects.


Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells responsible for voluntary muscle movement. As of now, there is no known cure for ALS, and the available treatments aim to alleviate symptoms and improve the quality of life for patients. In recent years, there has been growing interest in exploring the potential therapeutic benefits of cannabis as an adjuvant treatment for ALS. While the research is still in its early stages and inconclusive, preliminary findings suggest that cannabis may offer positive effects for ALS patients.

Addressing ALS Symptoms:

One of the most compelling aspects of cannabis as a potential treatment for ALS is its ability to address various symptoms associated with the disease. Cannabis has been found to possess properties such as analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction, which could greatly benefit ALS patients [5]. These symptom management properties may help alleviate pain, reduce spasticity, control excessive drooling, stimulate appetite, and improve sleep quality, leading to an improved overall quality of life for ALS patients [8][9].

Antioxidative, Anti-inflammatory, and Neuroprotective Effects:

Cannabis contains compounds known as cannabinoids, which have been shown to possess antioxidative, anti-inflammatory, and neuroprotective effects [6]. These properties are particularly relevant to ALS, as the disease involves oxidative stress, inflammation, and progressive damage to motor neurons. Preclinical studies on animal models of ALS have demonstrated that cannabis-based treatments can provide neuroprotection, delay disease onset, and slow disease progression [7]. While these findings are promising, further research is needed to fully understand the mechanisms underlying these effects and evaluate their potential in human ALS patients.

Patient Surveys and Observations:

Although clinical trials investigating the use of cannabis-based medicines specifically for ALS progression control are limited, patient surveys and anecdotal evidence suggest that medicinal cannabis may provide therapeutic relief for ALS symptoms, including pain, spasticity, and excessive drooling [3]. While not definitive, these observations indicate that cannabis could be a valuable adjunctive therapy for managing ALS symptoms and improving patients’ daily functioning.


The use of cannabis as an adjuvant treatment for ALS holds promise, primarily due to its symptom management properties and potential neuroprotective effects. While preclinical studies and patient surveys suggest therapeutic benefits, conclusive evidence regarding the efficacy and safety of cannabis in ALS is still lacking. As such, it is important for healthcare professionals, patients, and those interested in medicinal cannabis to recognize the need for further research and clinical trials to provide a clearer understanding of cannabis’ potential role in ALS treatment. Ultimately, through continued scientific investigation, we may uncover new avenues for improving the lives of ALS patients and potentially slowing the progression of this devastating disease.











Made in California, with the finest ingredients, bcure products are made one by one with the highest quality control.